WHO ICTRP trial
Investigating a Vaccine Against COVID-19
EUCTR2020-001228-32-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-001228-32-GB |
|---|---|
| Public title | Investigating a Vaccine Against COVID-19 |
| Scientific title | A phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 - Investigating a Vaccine Against COVID-19 (COV002) |
| Primary sponsor | CTRG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | SARS-CoV-2 MedDRA version: 23.0 Level: PT Classification code 10051905 Term: Coronavirus infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Interventions | Product Name: ChAdOx1 nCoV-19 Pharmaceutical Form: Solution for injection Trade Name: Nimenrix Product Name: Nimenrix Pharmaceutical Form: Powder and solvent for solution for injection Trade Name: Menveo Product Name: Menveo Pharmaceutical… |
| Registration date | Apr 21, 2020 |
| Target size | 12390 |
| Secondary IDs | COV002 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: